<DOC>
	<DOCNO>NCT00587964</DOCNO>
	<brief_summary>For patient one two metastasis brain , tumor ( ) often remove surgery relieve symptom tumor ( ) improve survival . However , half patient tumor ( ) remove surgery develop regrowth ( recurrence ) tumor . To prevent regrowth tumor , patient receive radiation entire brain ( whole brain radiation ) surgery . This involve daily treatment two three week , may cause long-term neurological problem , memory loss . Stereotactic radiosurgery ( SRS ) sometimes use instead surgery treat brain metastasis . This involve use special head frame sophisticated computer program enable u deliver high dose radiation small focus area brain one treatment . Research show result treatment SRS good surgical removal tumor . SRS surgical resection consider standard option treatment brain metastasis . This Phase II clinical trial study combination two technique . The purpose study evaluate use SRS follow surgical removal brain metastasis . The outcome look tumor regrowth treatment side effect treatment .</brief_summary>
	<brief_title>Phase II Trial Stereotactic Radiosurgery Boost Following Surgical Resection Brain Metastases</brief_title>
	<detailed_description>This phase II trial patient 1-2 brain metastasis treat surgical resection follow stereotactic radiosurgery boost . Following surgical resection , patient would receive stereotactic radiosurgery boost surgical bed , 2-8 week surgery . A dose 15 22 Gy would deliver single fraction . Patient would subsequently follow clinically radiologically watch local control well toxicity . If recurrence new metastasis ( e ) detect , treatment may give , consist chemotherapy , surgery , whole brain radiation therapy stereotactic radiotherapy .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<criteria>Histologically confirm malignancy presence one two intraparenchymal brain metastasis ( newly diagnose patient may register base radiologic confirmation pathology unavailable ) Age ≥ 18 year Karnofsky performance status ≥ 70 Neurologic Function Status 02 Patients may extracranial site metastatic disease Adequate bone marrow reserve ( hemoglobin ≥ 8 gram , absolute neutrophil count ≥ 1000/mm3 , platelet ≥ 50,000/mm3 ) Patient must sign study specific informed consent form . Major medical illness include poor cardiac , pulmonary renal status would result patient high risk candidate neurosurgical procedure Inability obtain histologic proof malignancy Patients leptomeningeal metastasis document MRI CSF evaluation Patients metastases within 10 mm optic apparatus portion optic nerve chiasm would include high dose SRS boost field Patients metastases brainstem , midbrain , pons , medulla Patients small cell lung cancer , germcell tumor , lymphoma , leukemia multiple myeloma eligible Younger 18 year age Karnofsky performance status ≤ 60 Prior history whole brain radiation therapy Concomitant use chemotherapy target biological therapy ( within week SRS treatment ) ≥ 3 metastasis brain Allergy CT MR contrast dyes Platelet count &lt; 100,000 coagulation disorder correct would render surgery highrisk procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Brain Metastasis</keyword>
	<keyword>Radiosurgery</keyword>
	<keyword>Bladder cancer</keyword>
	<keyword>Breast cancer</keyword>
	<keyword>Cervical cancer</keyword>
	<keyword>Colon cancer</keyword>
	<keyword>HEENT cancer</keyword>
	<keyword>Lung cancer</keyword>
	<keyword>Melanoma</keyword>
	<keyword>Pancreatic cancer</keyword>
	<keyword>Prostate cancer</keyword>
	<keyword>Rectal cancer</keyword>
	<keyword>Sarcoma</keyword>
	<keyword>Testicular cancer</keyword>
	<keyword>Radiation</keyword>
</DOC>